<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to determine the effect of <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorders</z:e>, including <z:e sem="disease" ids="C0815107" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychological distress</z:e> and <z:hpo ids='HP_0000716'>depression</z:hpo>, on <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome </plain></SENT>
<SENT sid="1" pm="."><plain>Male Fischer rats were exposed to immobilisation stress, an animal paradigm of <z:e sem="disease" ids="C0038443" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychological stress</z:e>, major <z:hpo ids='HP_0000716'>depression</z:hpo> and <z:e sem="disease" ids="C0038436" disease_type="Mental or Behavioral Dysfunction" abbrv="PTSD">post-traumatic stress disorder</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Either a <z:hpo ids='HP_0011011'>subacute</z:hpo> (1 h for 7 days) or a <z:hpo ids='HP_0011010'>chronic</z:hpo> (6 h for 21 days) exposure to stress was applied 24 h before permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> outcome was assessed by measurement of <z:mpath ids='MPATH_124'>infarct</z:mpath> size and behavioural characterisation </plain></SENT>
<SENT sid="4" pm="."><plain>Serum <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and brain ATP levels as well as brain <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter function and expression were studied in the search for the molecular mechanisms involved </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011011'>Subacute</z:hpo> stress exposure increased <z:mpath ids='MPATH_124'>infarct</z:mpath> size and decreased behavioural scores after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>On the contrary, <z:hpo ids='HP_0011010'>chronic</z:hpo> stress exposure decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="7" pm="."><plain>Peak serum <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> levels correlated with <z:mpath ids='MPATH_124'>infarct</z:mpath> size after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporters was decreased by <z:hpo ids='HP_0011011'>subacute</z:hpo> stress, whereas the expression of EAAT1, a glial <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> carrier, was increased after the <z:hpo ids='HP_0011010'>chronic</z:hpo> stress protocol </plain></SENT>
<SENT sid="9" pm="."><plain>Our results indicate that distinct patterns of stress determine different <z:hpo ids='HP_0001297'>stroke</z:hpo> outcomes, and that expressional changes of brain <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporters, able to affect <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release after <z:hpo ids='HP_0001297'>stroke</z:hpo>, are involved </plain></SENT>
</text></document>